View price in:  
Ebixa (Memantine)
click to see larger image

Ebixa (Memantine)

Treats moderate to severe Alzheimer's Disease
Works on various neurotransmitter receptors
Original Ebixa brand 
Size:
Our Price:
USD79.99
Free Delivery
EU Licensed Pharmacy
Ebixa (Memantine)
click to see larger image

Ebixa (Memantine)

Product Reviews

Write an online review and share your thoughts.

WHAT


Lundbeck Ltd developed Ebixa, the trade name for the drug Memantine, to help treat those with moderate to severe Alzheimer's Disease.  It works by blocking NMDA receptors which offers a different treatment modality which proved a benefit when considering the limited effectiveness of drugs targeting cholinergic pathways. As well as its effect on NMDA receptors, Ebixa also acts as an antagonist at the 5-HT3 receptor, as well as the nicotinic acetylcholine receptor while acting as a dopamine D2 agonist.

WHY


Ebixa offers a novel way of treating Alzheimer's and has a good safety record with side effects relatively low compared to other neurological diseases. Indeed, in recent years there has been extensive research conducted into whether Ebixa can offer assistance to others with diseases ranging from OCD, and anxiety to seeing if it can help in reversing the tolerance development to opiod based drugs.

WHO


Ebixa is primarily used in aged individuals for the simple reason that is the elderly who are prone to suffering from Alzheimer's Disease.

WHEN


Ebixa has no set rule governing its administration. Instead the patient's own healthcare provider will determine both dose, and frequency as well as how long it is administered for.

PATIENT LEAFLET

Treats moderate to severe Alzheimer's Disease
Works on various neurotransmitter receptors
Original Ebixa brand